GSK-711202/008

Study Sponsor: GSK

Study Title

Evaluate the persistence and immune memory induced by a primary vaccination course with GSK Biologicals’ MenC-TT (1 formulation) & GSK Biologicals’ Hib-MenC-TT (2 formulations) or Meningitec™ in healthy toddlers aged 12-15 mths primed in study 711202/001

Medicine or Vaccine (generic name)

Meningococcal Vaccine

Sponsor Identification Number

711202/008

Trial Registry Identification Number(#'s)

NCT00135564

Medical Condition

Infections, Meningococcal

Phase

Phase 2

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=711202/008

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00135564

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This is a persistence study of 711202/001. An annotated case report form is not available for this study. A blank case report form will be provided.

Date Added to this Site

June 2015